CLBCX | JBALX | CLBCX / JBALX | |
Total Expense Ratio | 1.35 | 0.66 | 205% |
Annual Report Gross Expense Ratio | 1.35 | 0.66 | 205% |
Fund Existence | 24 years | 16 years | - |
Gain YTD | 12.509 | 12.686 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 262B | 27.6B | 949% |
Annual Yield % from dividends | 1.11 | 1.79 | 62% |
Returns for 1 year | 9.48 | 9.33 | 102% |
Returns for 3 years | 39.75 | 40.90 | 97% |
Returns for 5 years | 39.67 | 43.12 | 92% |
Returns for 10 years | 77.37 | 103.54 | 75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HIMZ | 22.40 | 2.82 | +14.40% |
Defiance Daily Target 2X Long HIMS ETF | |||
TXS | 36.11 | N/A | N/A |
Texas Capital Texas Equity Index ETF | |||
FIDI | 24.63 | -0.08 | -0.32% |
Fidelity International High Div ETF | |||
VPL | 88.90 | -0.33 | -0.37% |
Vanguard FTSE Pacific ETF | |||
LABU | 78.72 | -4.02 | -4.86% |
Direxion Daily S&P Biotech Bull 3X ETF |